These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20298422)

  • 1. Corticolimbic gray matter loss in Parkinson's disease without dementia.
    Nishio Y; Hirayama K; Takeda A; Hosokai Y; Ishioka T; Suzuki K; Itoyama Y; Takahashi S; Mori E
    Eur J Neurol; 2010 Aug; 17(8):1090-7. PubMed ID: 20298422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter differences contribute to variation in cognitive performance in Parkinson's disease.
    Gerrits NJ; van der Werf YD; Hofman M; Foncke EM; Klein M; Berendse HW; van den Heuvel OA
    Eur J Neurol; 2014 Feb; 21(2):245-52. PubMed ID: 24112523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients.
    Lee EY; Sen S; Eslinger PJ; Wagner D; Shaffer ML; Kong L; Lewis MM; Du G; Huang X
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1088-93. PubMed ID: 23932064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
    Meppelink AM; de Jong BM; Teune LK; van Laar T
    Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC
    Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.
    Song SK; Lee JE; Park HJ; Sohn YH; Lee JD; Lee PH
    Mov Disord; 2011 Feb; 26(2):289-96. PubMed ID: 21370255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms in Parkinson's disease: fronto-striatal atrophy contributions.
    O'Callaghan C; Shine JM; Lewis SJ; Hornberger M
    Parkinsonism Relat Disord; 2014 Aug; 20(8):867-72. PubMed ID: 24866458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease.
    Lee JE; Cho KH; Ham JH; Song SK; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Feb; 20(2):186-91. PubMed ID: 24262869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.
    Ibarretxe-Bilbao N; Ramírez-Ruiz B; Tolosa E; Martí MJ; Valldeoriola F; Bargalló N; Junqué C
    J Neurol; 2008 Sep; 255(9):1324-31. PubMed ID: 18821043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.